With 20 years tenure in the healthcare industry, Orli brings vast management experience spanning across several industries including healthcare, consumer health and digital health.
She was the CEO of Neopharm Israel, a $200 million company and one of Israel’s leading providers of innovative integrated solutions across the healthcare spectrum. Orli also served as CEO of BIRAD Ltd., managing Bar Ilan University’s IP and commercialization efforts as well as all research collaborations with the industry. During her tenure, the company built a diverse portfolio of start-up companies based on university IP.
Orli has served as a board member at Collplant Ltd. (CLPT) and Alcobra (ADHD) and is former Chairperson of the Israeli Technology Transfer Organization.
Orli obtained her M.Sc. in Microbiology (magna cum laude) at Tel Aviv University, School of Medicine and graduated the Executive Program for senior business managers at the Tel Aviv University School of Business.